Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2023-05-26 Earnings Release
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated May 26, 2023, announcing the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2023. It contains detailed financial data including revenue, EBITDA, profit and loss snapshots, business segment performance, and R&D expenditure. The document is 8,383 characters long, which is substantial and contains actual financial results and analysis, not just a brief announcement or a link to a report. The content aligns with an Earnings Release (ER) as it provides initial quarterly and annual financial results highlights. It is not a full Annual Report (10-K) or Interim Report (IR) since it focuses on quarterly and yearly results in a summarized press release format. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive financial data rather than just a notification or certification. Therefore, the appropriate classification is Earnings Release (ER).
2023-05-26 English
Financial Result Updates
Regulatory Filings
2023-05-26 English
Outcome of Board Meeting
Regulatory Filings
2023-05-26 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements. It informs about a Settlement Order from SEBI regarding a show cause notice related to a past USFDA inspection issue. The document details the settlement terms and payments but does not contain any financial statements, detailed financial data, or comprehensive report content. It is an announcement of a regulatory settlement and related information rather than a full report or financial filing. The document length is short (2313 characters), and it serves as an official regulatory update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-23 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-23 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references Regulation 39(3) of SEBI Listing Regulations, which pertains to share certificate loss and related disclosures. The content is about notifying the exchanges and market participants to restrain trading on the lost certificates and does not contain financial data, earnings, management discussion, or any report publication. It is a regulatory announcement related to share certificates but not a financial report or management information. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-05-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.